Skip to content
Open access

RAB37 Exerts a Context-Dependent Role in Cutaneous Melanoma Progression by Promoting Tumor Cell Proliferation and Being Associated with Favorable Immune Characteristics

Aug 2026 · Cancer Management and Research · Vol 18, pp. 1-18 · 0 citations · 46 references
Medicine

TL;DR

RAB37 exhibits a context-dependent role in CM by promoting malignant cellular behaviors while being associated with immune-related characteristics and favorable clinical outcomes, and this study suggests that RAB37 may serve as a potential prognostic biomarker.

Abstract

Background Rab proteins and small GTPase-mediated vesicle trafficking pathways play important roles in tumor progression and the tumor microenvironment. However, the biological function and clinical significance of RAB37 in cutaneous melanoma (CM) remain unclear. This study investigated the expression pattern, prognostic value, biological function, and immune-related characteristics of RAB37 in CM. Methods RAB37 expression and prognostic significance were analyzed using The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets. Kaplan–Meier and Cox regression analyses were performed to evaluate prognostic value. Spearman correlation analysis assessed associations between RAB37 expression and immune cell infiltration, immune checkpoint blockade (ICB)-related signatures, and inflammatory cytokines. Functional roles of RAB37 were validated using loss- and gain-of-function experiments in A375 and WM-115 melanoma cells. CCK-8, EdU, and Transwell assays evaluated cell proliferation and migration. Single-cell functional analysis was performed using CancerSEA. Results RAB37 expression was significantly higher in metastatic than in primary CM tissues. Elevated RAB37 expression and hypermethylation of the cg26263675 CpG site were associated with favorable survival outcomes. A prognostic nomogram integrating clinicopathological characteristics and RAB37 methylation was established. Functional experiments demonstrated that RAB37 knockdown significantly inhibited, whereas RAB37 overexpression promoted, melanoma cell proliferation and migration in both A375 and WM-115 cells. RAB37 expression was significantly associated with immune cell infiltration, ICB-related signatures, inflammatory cytokines, and immune-related pathways, including T-cell receptor signaling, PD-1 checkpoint signaling, IL-2/STAT5 signaling, and inflammatory responses. Single-cell analysis further revealed a positive association between RAB37 expression and inflammation-related functional states. Conclusion RAB37 exhibits a context-dependent role in CM by promoting malignant cellular behaviors while being associated with immune-related characteristics and favorable clinical outcomes. These findings suggest that RAB37 may serve as a potential prognostic biomarker and provide new insights into the interplay between CM progression and the tumor immune microenvironment.

Read PDF

Similar papers

Open access Sep 2026

Prognostic Value of VPS45 in HCC and Its Correlation with Immune Microenvironment

The biological role of VPS45 in hepatocellular carcinoma (HCC) is clarified and, through comprehensive database analyses combined with in vitro experiments, supports its potential as a diagnostic and predictive biomarker for HCC.

Ji-Ming Duan, Wen-Jun Zhao, Na Lv et al. · 0 citations
Open access Sep 2026

Pan‐Cancer Analysis of the Immunomodulatory Roles and Prognostic Value of PDXP and Experimental Verification in SKCM

ABSTRACT Multiple public databases, including TCGA, GEO, and TARGET, were utilized to comprehensively analyze pyridoxal phosphatase (PDXP) expression profiles across 34 cancer types. We further explored the associations of PDXP expression with clinicopathological features, tumor immune microenvironment, genomic heterog...

Ying-Jian Hu, Xin-Zhu Zeng, Wei Cao et al. · 0 citations
Open access Aug 2026

IFI44L modulates chemoradiotherapy sensitivity and CD8+ T cell infiltration in colorectal cancer

Objective Chemoradiotherapy (CRT) represents a cornerstone treatment for colorectal cancer (CRC), yet heterogeneous responses to CRT in treatment response remain a major clinical challenge. Increasing evidence suggests that the tumor immune microenvironment (TME) especially intratumoral CD8+ T cells plays an important...

Linlin Zheng, Meng-Jie Li, Ruoqing Yan et al. · 0 citations
Aug 2026

CDC20B Dysregulation: Links to Tumor Prognosis and Immunity.

OBJECTIVE This study aimed to clarify the pan-cancer expression pattern, upstream regulatory mechanisms, prognostic relevance, and immune associations of CDC20B. METHOD Using public databases (GTEx, GEO, and TCGA), we examined CDC20B expression and its associations with prognosis and tumor immunity across multiple ca...

Hong-Rong Wu, Liang-Li Hong · 0 citations
Open access Sep 2026

RAMP3 is associated with macrophage-driven immune exclusion and promotes resistance to PD-1 blockade in breast cancer: integrated in vivo and single-cell transcriptomic analyses

The results suggest that RAMP3 contributed to the establishment of an immunosuppressive TME and integration with human clinical datasets supports further investigation of RAMP3 as a potential therapeutic target for overcoming resistance to immune checkpoint therapy in breast cancer.

Yan Zhang, Megumu Tanaka, T. Sakurai et al. · 0 citations
Open access Aug 2026

Autocrine Control of CD276 by SPARC in Liver Cancer and Its Contribution to Immune Escape and Resistance to Immunotherapy

ABSTRACT Hepatocellular carcinoma (HCC) frequently demonstrates resistance to immunotherapeutic interventions, a phenomenon largely linked to mechanisms of immune escape. Among the modulators of the tumor microenvironment, SPARC (Secreted Protein Acidic and Rich in Cysteine), a matricellular glycoprotein, has been asso...

Meng-Ying Tang, Jing Liu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.